The global Autoimmune Disorder Drug Delivery Device market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
AbbVie Inc.
Bayer AG
Novartis AG
Amgen Inc.
Merck KGaA
F. Hoffmann- La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Biogen Inc.
GlaxoSmithKline Plc
Johnson & Johnson Services Inc.
Eli Lily and Company
Sanofi S.A.
Takeda Pharmaceutical Company Limited
By Types:
Pen Injectors
Auto-Injectors
Prefilled Syringes
Vials
By Applications:
In-house Manufacturing
Outsourced Manufacturing
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Autoimmune Disorder Drug Delivery Device Market Size Analysis from 2023 to 2028
1.5.1 Global Autoimmune Disorder Drug Delivery Device Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Autoimmune Disorder Drug Delivery Device Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Autoimmune Disorder Drug Delivery Device Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Autoimmune Disorder Drug Delivery Device Industry Impact
Chapter 2 Global Autoimmune Disorder Drug Delivery Device Competition by Types, Applications, and Top Regions and Countries
2.1 Global Autoimmune Disorder Drug Delivery Device (Volume and Value) by Type
2.1.1 Global Autoimmune Disorder Drug Delivery Device Consumption and Market Share by Type (2017-2022)
2.1.2 Global Autoimmune Disorder Drug Delivery Device Revenue and Market Share by Type (2017-2022)
2.2 Global Autoimmune Disorder Drug Delivery Device (Volume and Value) by Application
2.2.1 Global Autoimmune Disorder Drug Delivery Device Consumption and Market Share by Application (2017-2022)
2.2.2 Global Autoimmune Disorder Drug Delivery Device Revenue and Market Share by Application (2017-2022)
2.3 Global Autoimmune Disorder Drug Delivery Device (Volume and Value) by Regions
2.3.1 Global Autoimmune Disorder Drug Delivery Device Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Autoimmune Disorder Drug Delivery Device Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Autoimmune Disorder Drug Delivery Device Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Autoimmune Disorder Drug Delivery Device Consumption by Regions (2017-2022)
4.2 North America Autoimmune Disorder Drug Delivery Device Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Autoimmune Disorder Drug Delivery Device Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Autoimmune Disorder Drug Delivery Device Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Autoimmune Disorder Drug Delivery Device Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Autoimmune Disorder Drug Delivery Device Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Autoimmune Disorder Drug Delivery Device Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Autoimmune Disorder Drug Delivery Device Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Autoimmune Disorder Drug Delivery Device Sales, Consumption, Export, Import (2017-2022)
4.10 South America Autoimmune Disorder Drug Delivery Device Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Autoimmune Disorder Drug Delivery Device Market Analysis
5.1 North America Autoimmune Disorder Drug Delivery Device Consumption and Value Analysis
5.1.1 North America Autoimmune Disorder Drug Delivery Device Market Under COVID-19
5.2 North America Autoimmune Disorder Drug Delivery Device Consumption Volume by Types
5.3 North America Autoimmune Disorder Drug Delivery Device Consumption Structure by Application
5.4 North America Autoimmune Disorder Drug Delivery Device Consumption by Top Countries
5.4.1 United States Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
5.4.2 Canada Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
5.4.3 Mexico Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
Chapter 6 East Asia Autoimmune Disorder Drug Delivery Device Market Analysis
6.1 East Asia Autoimmune Disorder Drug Delivery Device Consumption and Value Analysis
6.1.1 East Asia Autoimmune Disorder Drug Delivery Device Market Under COVID-19
6.2 East Asia Autoimmune Disorder Drug Delivery Device Consumption Volume by Types
6.3 East Asia Autoimmune Disorder Drug Delivery Device Consumption Structure by Application
6.4 East Asia Autoimmune Disorder Drug Delivery Device Consumption by Top Countries
6.4.1 China Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
6.4.2 Japan Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
6.4.3 South Korea Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
Chapter 7 Europe Autoimmune Disorder Drug Delivery Device Market Analysis
7.1 Europe Autoimmune Disorder Drug Delivery Device Consumption and Value Analysis
7.1.1 Europe Autoimmune Disorder Drug Delivery Device Market Under COVID-19
7.2 Europe Autoimmune Disorder Drug Delivery Device Consumption Volume by Types
7.3 Europe Autoimmune Disorder Drug Delivery Device Consumption Structure by Application
7.4 Europe Autoimmune Disorder Drug Delivery Device Consumption by Top Countries
7.4.1 Germany Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
7.4.2 UK Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
7.4.3 France Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
7.4.4 Italy Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
7.4.5 Russia Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
7.4.6 Spain Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
7.4.7 Netherlands Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
7.4.8 Switzerland Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
7.4.9 Poland Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
Chapter 8 South Asia Autoimmune Disorder Drug Delivery Device Market Analysis
8.1 South Asia Autoimmune Disorder Drug Delivery Device Consumption and Value Analysis
8.1.1 South Asia Autoimmune Disorder Drug Delivery Device Market Under COVID-19
8.2 South Asia Autoimmune Disorder Drug Delivery Device Consumption Volume by Types
8.3 South Asia Autoimmune Disorder Drug Delivery Device Consumption Structure by Application
8.4 South Asia Autoimmune Disorder Drug Delivery Device Consumption by Top Countries
8.4.1 India Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
8.4.2 Pakistan Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Autoimmune Disorder Drug Delivery Device Market Analysis
9.1 Southeast Asia Autoimmune Disorder Drug Delivery Device Consumption and Value Analysis
9.1.1 Southeast Asia Autoimmune Disorder Drug Delivery Device Market Under COVID-19
9.2 Southeast Asia Autoimmune Disorder Drug Delivery Device Consumption Volume by Types
9.3 Southeast Asia Autoimmune Disorder Drug Delivery Device Consumption Structure by Application
9.4 Southeast Asia Autoimmune Disorder Drug Delivery Device Consumption by Top Countries
9.4.1 Indonesia Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
9.4.2 Thailand Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
9.4.3 Singapore Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
9.4.4 Malaysia Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
9.4.5 Philippines Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
9.4.6 Vietnam Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
9.4.7 Myanmar Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
Chapter 10 Middle East Autoimmune Disorder Drug Delivery Device Market Analysis
10.1 Middle East Autoimmune Disorder Drug Delivery Device Consumption and Value Analysis
10.1.1 Middle East Autoimmune Disorder Drug Delivery Device Market Under COVID-19
10.2 Middle East Autoimmune Disorder Drug Delivery Device Consumption Volume by Types
10.3 Middle East Autoimmune Disorder Drug Delivery Device Consumption Structure by Application
10.4 Middle East Autoimmune Disorder Drug Delivery Device Consumption by Top Countries
10.4.1 Turkey Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
10.4.3 Iran Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
10.4.5 Israel Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
10.4.6 Iraq Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
10.4.7 Qatar Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
10.4.8 Kuwait Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
10.4.9 Oman Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
Chapter 11 Africa Autoimmune Disorder Drug Delivery Device Market Analysis
11.1 Africa Autoimmune Disorder Drug Delivery Device Consumption and Value Analysis
11.1.1 Africa Autoimmune Disorder Drug Delivery Device Market Under COVID-19
11.2 Africa Autoimmune Disorder Drug Delivery Device Consumption Volume by Types
11.3 Africa Autoimmune Disorder Drug Delivery Device Consumption Structure by Application
11.4 Africa Autoimmune Disorder Drug Delivery Device Consumption by Top Countries
11.4.1 Nigeria Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
11.4.2 South Africa Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
11.4.3 Egypt Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
11.4.4 Algeria Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
11.4.5 Morocco Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
Chapter 12 Oceania Autoimmune Disorder Drug Delivery Device Market Analysis
12.1 Oceania Autoimmune Disorder Drug Delivery Device Consumption and Value Analysis
12.2 Oceania Autoimmune Disorder Drug Delivery Device Consumption Volume by Types
12.3 Oceania Autoimmune Disorder Drug Delivery Device Consumption Structure by Application
12.4 Oceania Autoimmune Disorder Drug Delivery Device Consumption by Top Countries
12.4.1 Australia Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
12.4.2 New Zealand Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
Chapter 13 South America Autoimmune Disorder Drug Delivery Device Market Analysis
13.1 South America Autoimmune Disorder Drug Delivery Device Consumption and Value Analysis
13.1.1 South America Autoimmune Disorder Drug Delivery Device Market Under COVID-19
13.2 South America Autoimmune Disorder Drug Delivery Device Consumption Volume by Types
13.3 South America Autoimmune Disorder Drug Delivery Device Consumption Structure by Application
13.4 South America Autoimmune Disorder Drug Delivery Device Consumption Volume by Major Countries
13.4.1 Brazil Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
13.4.2 Argentina Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
13.4.3 Columbia Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
13.4.4 Chile Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
13.4.5 Venezuela Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
13.4.6 Peru Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
13.4.8 Ecuador Autoimmune Disorder Drug Delivery Device Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Autoimmune Disorder Drug Delivery Device Business
14.1 AbbVie Inc.
14.1.1 AbbVie Inc. Company Profile
14.1.2 AbbVie Inc. Autoimmune Disorder Drug Delivery Device Product Specification
14.1.3 AbbVie Inc. Autoimmune Disorder Drug Delivery Device Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Bayer AG
14.2.1 Bayer AG Company Profile
14.2.2 Bayer AG Autoimmune Disorder Drug Delivery Device Product Specification
14.2.3 Bayer AG Autoimmune Disorder Drug Delivery Device Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Novartis AG
14.3.1 Novartis AG Company Profile
14.3.2 Novartis AG Autoimmune Disorder Drug Delivery Device Product Specification
14.3.3 Novartis AG Autoimmune Disorder Drug Delivery Device Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Amgen Inc.
14.4.1 Amgen Inc. Company Profile
14.4.2 Amgen Inc. Autoimmune Disorder Drug Delivery Device Product Specification
14.4.3 Amgen Inc. Autoimmune Disorder Drug Delivery Device Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Merck KGaA
14.5.1 Merck KGaA Company Profile
14.5.2 Merck KGaA Autoimmune Disorder Drug Delivery Device Product Specification
14.5.3 Merck KGaA Autoimmune Disorder Drug Delivery Device Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 F. Hoffmann- La Roche Ltd.
14.6.1 F. Hoffmann- La Roche Ltd. Company Profile
14.6.2 F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Product Specification
14.6.3 F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Teva Pharmaceutical Industries Ltd.
14.7.1 Teva Pharmaceutical Industries Ltd. Company Profile
14.7.2 Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Product Specification
14.7.3 Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Biogen Inc.
14.8.1 Biogen Inc. Company Profile
14.8.2 Biogen Inc. Autoimmune Disorder Drug Delivery Device Product Specification
14.8.3 Biogen Inc. Autoimmune Disorder Drug Delivery Device Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 GlaxoSmithKline Plc
14.9.1 GlaxoSmithKline Plc Company Profile
14.9.2 GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Product Specification
14.9.3 GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Johnson & Johnson Services Inc.
14.10.1 Johnson & Johnson Services Inc. Company Profile
14.10.2 Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Product Specification
14.10.3 Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Eli Lily and Company
14.11.1 Eli Lily and Company Company Profile
14.11.2 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Product Specification
14.11.3 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Sanofi S.A.
14.12.1 Sanofi S.A. Company Profile
14.12.2 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Product Specification
14.12.3 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Takeda Pharmaceutical Company Limited
14.13.1 Takeda Pharmaceutical Company Limited Company Profile
14.13.2 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Product Specification
14.13.3 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Autoimmune Disorder Drug Delivery Device Market Forecast (2023-2028)
15.1 Global Autoimmune Disorder Drug Delivery Device Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Autoimmune Disorder Drug Delivery Device Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Autoimmune Disorder Drug Delivery Device Value and Growth Rate Forecast (2023-2028)
15.2 Global Autoimmune Disorder Drug Delivery Device Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Autoimmune Disorder Drug Delivery Device Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Autoimmune Disorder Drug Delivery Device Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Autoimmune Disorder Drug Delivery Device Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Autoimmune Disorder Drug Delivery Device Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Autoimmune Disorder Drug Delivery Device Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Autoimmune Disorder Drug Delivery Device Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Autoimmune Disorder Drug Delivery Device Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Autoimmune Disorder Drug Delivery Device Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Autoimmune Disorder Drug Delivery Device Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Autoimmune Disorder Drug Delivery Device Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Autoimmune Disorder Drug Delivery Device Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Autoimmune Disorder Drug Delivery Device Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Autoimmune Disorder Drug Delivery Device Consumption Forecast by Type (2023-2028)
15.3.2 Global Autoimmune Disorder Drug Delivery Device Revenue Forecast by Type (2023-2028)
15.3.3 Global Autoimmune Disorder Drug Delivery Device Price Forecast by Type (2023-2028)
15.4 Global Autoimmune Disorder Drug Delivery Device Consumption Volume Forecast by Application (2023-2028)
15.5 Autoimmune Disorder Drug Delivery Device Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 3500 |
Date : Apr 2024 |
| Category : Services |
Pages : 139 |
| Price : US$ 3500 |
Date : Apr 2024 |
| Category : Electronics |
Pages : 129 |
Request Sample 
Request Discount 
Inquire Before Buy
